Navigation Links
UNC scientists turn human skin cells into insulin-producing cells
Date:9/17/2008

CHAPEL HILL Researchers at the University of North Carolina at Chapel Hill School of Medicine have transformed cells from human skin into cells that produce insulin, the hormone used to treat diabetes.

The breakthrough may one day lead to new treatments or even a cure for the millions of people affected by the disease, researchers say.

The approach involves reprogramming skin cells into pluripotent stem cells, or cells that can give rise to any other fetal or adult cell type, and then inducing them to differentiate, or transform, into cells that perform a particular function in this case, secreting insulin.

Several recent studies have shown that cells can be returned to pluripotent state using "defined factors" (specific proteins that control which genes are active in a cell), a technique pioneered by Dr. Shinya Yamanaka, a professor at Kyoto University in Japan.

However, the UNC study is the first to demonstrate that cells reprogrammed in this way can be coaxed to differentiate into insulin-secreting cells. Results of the study are published online in the Journal of Biological Chemistry.

"Not only have we shown that we can reprogram skin cells, but we have also demonstrated that these reprogrammed cells can be differentiated into insulin-producing cells which hold great therapeutic potential for diabetes," said study lead author Yi Zhang, Ph.D., Howard Hughes Medical Institute investigator, professor of biochemistry and biophysics at UNC and member of the Lineberger Comprehensive Cancer Center.

"Of course, there are many years of additional studies that are required first, but this study provides hope for a cure for all patients with diabetes," said John Buse, M.D., Ph.D., president of the American Diabetes Association and professor and chief of the endocrinology division in the UNC School of Medicine's department of medicine.

About 24 million Americans suffer from diabetes, a disease that occurs when the body is unable to produce or use insulin properly. Virtually all patients with type I diabetes, the more severe of the two types, must rely on daily injections of insulin to maintain their blood sugar levels.

Recent research exploring a possible long-term treatment the transplantation of insulin-producing beta cells into patients has yielded promising results. But this approach faces its own challenges, given the extreme shortage of matched organ donors and the need to suppress patients' immune systems.

The work by Zhang and other researchers could potentially address those problems, since insulin-producing cells could be made from diabetic patients' own reprogrammed cells.

Zhang is collaborating with Buse to obtain skin samples from diabetes patients. He said he hoped his current experiments will take this approach one step closer to a new treatment or even a cure for diabetes.


'/>"/>

Contact: Les Lang
llang@med.unc.edu
919-966-9366
University of North Carolina School of Medicine
Source:Eurekalert  

Related biology news :

1. Scientists isolate cancer stem cells
2. Scientists form alliance to develop nanotoxicology protocols
3. Scientists point to forests for carbon storage solutions
4. US Air Force technology helps scientists understand plant root function
5. Best way to treat malaria: Avoid using same drug for everyone, scientists say
6. Scientists uncover Ebola cell-invasion strategy
7. Scientists use remote satellite imaging to predict outbreaks of infectious disease
8. Scientists develop new method to investigate origin of life
9. Caltech scientists create DNA tubes with programmable sizes for nanoscale manufacturing
10. Indiana U researchers launch social networking and research management tool for scientists
11. CSHL scientists identify new drug target against virulent type of breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UNC scientists turn human skin cells into insulin-producing cells
(Date:5/14/2020)... ... May 12, 2020 , ... ... Manufacturers accurately and easily project contracted liabilities with payers, providers and pharmacies ... projecting discounts/rebates to Commercial and Government entities, Copay and Patient Assistance Program ...
(Date:5/14/2020)... ... May 14, 2020 , ... The annual salary ... found the 2019 average medical sales rep total compensation increased by $12,000 over ... amid the COVID-19 global crisis. , The MedReps 2020 Salary Survey revealed yet ...
(Date:5/6/2020)... ... May 06, 2020 , ... Sickle Cell Disease Association ... technology company dedicated to improving the quality, safety, efficacy and cost of red blood ... SCDAA deliver on its mission and meet its goals. In 2020 Hemanext will collaborate ...
Breaking Biology News(10 mins):
(Date:4/26/2020)... ... April 23, 2020 , ... Indegene Omnipresence, Inc. announced the ... and services for use on Microsoft Azure. The customer experience management (CXM) technology ... for a built-for-purpose customer engagement capability to use in their commercial or medical ...
(Date:4/22/2020)... ... April 21, 2020 , ... Aniara Diagnostica is pleased ... , Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well ... product quality and cost-efficient delivery. , For Research Use Only. Not ...
(Date:4/7/2020)... ... , ... Gateway Genomics , leading developer of direct-to-consumer genetic tests that ... Tests sold in March, just months after attaining the 150,000-test landmark in late ... mom could order her kit online, collect a DNA sample from her home, mail ...
(Date:4/1/2020)... ... 2020 , ... A joint venture between mobile health provider ... year to bring telehealth to various government agencies, has now focused its attention ... currently?awaiting an Emergency Use Authorization (EUA) waiver from the FDA?to?perform?AI?testing in the U.S. ...
Breaking Biology Technology: